Ki Won Hwang
Overview
Explore the profile of Ki Won Hwang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cho M, Kang D, Ahn J, Yun S, Oh Y, Lee C, et al.
N Engl J Med
. 2024 Sep;
391(22):2075-2086.
PMID: 39225258
Background: Despite consistent recommendations from clinical guidelines, data from randomized trials on a long-term antithrombotic treatment strategy for patients with atrial fibrillation and stable coronary artery disease are still lacking....
2.
Roh J, Kim Y, Kim D, Park S, Park K, Kim M, et al.
Sci Rep
. 2024 Jun;
14(1):14679.
PMID: 38918543
In Asian patients with atrial fibrillation (AF) and end-stage renal disease (ESRD) undergoing dialysis, the use of direct oral anticoagulants (DOACs) remains debatable. From the national health insurance claims data...
3.
Cho M, Lee J, Nam G, Hwang K, Cha M, Kim J, et al.
BMC Cardiovasc Disord
. 2024 May;
24(1):246.
PMID: 38730404
Background: Clinical outcomes after catheter ablation (CA) or pacemaker (PM) implantation for the tachycardia-bradycardia syndrome (TBS) has not been evaluated adequately. We tried to compare the efficacy and safety outcomes...
4.
Lim J, Lee S, Ju M, Kim S, Choi J, Chon M, et al.
Int J Heart Fail
. 2023 May;
5(2):91-99.
PMID: 37180560
Background And Objectives: Recently, approximately 40% of all heart transplantation (HTx) in South Korea are performed using the direct extracorporeal membrane oxygenation (ECMO) bridging method. We conducted a study to...
5.
Lee S, Kim S, Ju M, Lim M, Lee C, Je H, et al.
Korean Circ J
. 2023 May;
53(4):254-267.
PMID: 37161684
Background And Objectives: Although the shortage of donor is a common problem worldwide, a significant portion of unutilized hearts are classified as marginal donor (MD) hearts. However, research on the...
6.
Cho M, Choi H, Hwang K, Kim J, Nam G, Choi K
BMC Cardiovasc Disord
. 2023 Apr;
23(1):209.
PMID: 37098477
Background: The clinical benefits and risks of anticoagulation therapy in patients with chronic kidney disease (CKD) are still inconclusive. We describe the outcomes of patients with atrial fibrillation (AF) after...
7.
Hwang K, Choi J, Lee S, Lee S, Chon M, Lee J, et al.
BMC Cardiovasc Disord
. 2023 Apr;
23(1):182.
PMID: 37016321
Background: Evidence and guidelines for Non-vitamin K antagonist oral anticoagulants (NOACs) use when prescribing concurrent rifampin for tuberculosis treatment in patients with non-valvular atrial fibrillation (NVAF) are limited. Methods: Using...
8.
Choi J, Chun K, Jung S, Lee S, Chon M, Lee S, et al.
BMC Cardiovasc Disord
. 2022 May;
22(1):207.
PMID: 35538419
Background: Compared to simple percutaneous coronary intervention (PCI), complex PCI is associated with higher bleeding and thrombotic risk. No previous study has evaluated the use of protamine after PCI with...
9.
Cho M, Kang D, Oh Y, Lee C, Choi E, Lee J, et al.
Am Heart J
. 2022 Feb;
247:123-131.
PMID: 35149036
Background: Anticoagulants are the standard therapy for patients with atrial fibrillation (AF) and antiplatelet therapy for those with coronary artery disease (CAD). However, compelling clinical evidence is still lacking regarding...
10.
Han S, Park G, Kim Y, Hwang K, Kwon C, Roh J, et al.
Sci Rep
. 2021 Mar;
11(1):3705.
PMID: 33723278
This study compared the characteristics and mortality of new implantation of cardiac implantable electronic device (CIED) between tertiary and non-tertiary hospitals. From national health insurance claims data in Korea, 17,655...